A recent study conducted by the University of Eastern Finland has unveiled promising findings regarding the positive impact of fatty fish consumption on cardiovascular health in individuals with impaired glucose metabolism or coronary heart disease.
Published in Nutrition, Metabolism & Cardiovascular Diseases, the study focused on the lipophilic index, a marker of cell membrane fluidity associated with cardiovascular risk.
The research, drawing data from two randomized clinical trials, revealed that a lower lipophilic index, signifying improved membrane fluidity, was observed in participants consuming fatty fish four times a week over 12 weeks.
This positive change was linked to larger mean HDL particle size and higher concentrations of large HDL particles, indicating potential cardiovascular benefits. Importantly, the study found that eating lean fish or camelina sativa oil did not produce similar effects on the lipophilic index.
The results highlight the potential of incorporating fatty fish into the diet to enhance cardiovascular health for individuals with glucose metabolism concerns. Further investigations are warranted to delve into the underlying mechanisms of these observed benefits.
